Clinical Study of GH001 in Depression

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

November 6, 2021

Study Completion Date

November 6, 2021

Conditions

Treatment Resistant DepressionMajor Depressive DisorderDepression

Interventions

DRUG

5 Methoxy N,N Dimethyltryptamine

GH001 administered via inhalation

Trial Locations (1)

Clinical Trial Site, Maastricht

All Listed Sponsors

lead

GH Research Ireland Limited

INDUSTRY

NCT04698603 - Clinical Study of GH001 in Depression | Biotech Hunter | Biotech Hunter